{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:46:07Z","timestamp":1754153167610,"version":"3.41.2"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-036519"],"award-info":[{"award-number":["INV-036519"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","award":["16\/136\/111"],"award-info":[{"award-number":["16\/136\/111"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Oyo State, Nigeria, reported its first coronavirus disease 2019 (COVID-19) case on 21 March 2020 and subsequently recorded the fifth highest number of cases in Nigeria, most in the capital city Ibadan. We aimed to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that were circulating in Ibadan between August 2021 and August 2022 and to assess the utility of healthcare worker (HCW)\u2013associated infections for endemic COVID-19 surveillance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Following ethical approval, SARS-CoV-2 real-time quantitative polymerase chain reaction (RT-qPCR)\u2013confirmed samples were reverse-transcribed and sequenced on an Illumina MiSeq using ARTIC SARS-CoV-2 RT-PCR and sequencing protocols. Genomes were assembled using the nf-core\/viralrecon pipeline. Quality control, phylogenetic, analysis, and variant identification were performed using publicly available software implemented in a custom Nextflow pipeline. Biodata and relevant clinical information were obtained from electronic case investigation forms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We analyzed 258 samples with minimum non-N coverage of 70% and identified 12 SARS-CoV-2 lineages and 7 clades, all but one aligning with global lineages. Lineages BA.1 (22%) and BA.1.1 (48%) were the most common. Delta lineage predominated from August to September 2021, and was replaced by Omicron lineage from December 2021. Samples from HCWs (n = 60; 23%) accounted for a third (4 of 12) of all major lineages observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We contributed 258 genomes from Oyo State to the GSAID repository and identified Delta and Omicron lineages circulating in Ibadan, in temporal alignment with global circulating lineages. As clinical testing declines HCWs are useful sentinels for genomic epidemiology capturing much of the diversity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaf056","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:05:44Z","timestamp":1753200344000},"page":"S29-S36","source":"Crossref","is-referenced-by-count":0,"title":["Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria"],"prefix":"10.1093","volume":"80","author":[{"given":"Elizabeth T","family":"Akande","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-7600","authenticated-orcid":false,"given":"Adeola A","family":"Fowotade","sequence":"additional","affiliation":[{"name":"Biorepository Clinical Virology Laboratory, College of Medicine, University of Ibadan, Ibadan ,","place":["Nigeria"]},{"name":"University College Hospital and College of Medicine , University of Ibadan, Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4503-9403","authenticated-orcid":false,"given":"Erkison Ewomazino","family":"Odih","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson O","family":"Oaikhena","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olasunkanmi","family":"Olisa","sequence":"additional","affiliation":[{"name":"Biorepository Clinical Virology Laboratory, College of Medicine, University of Ibadan, Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-2164","authenticated-orcid":false,"given":"Gabriel Temitope","family":"Sunmonu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boluwatife","family":"Adebiyi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-7189","authenticated-orcid":false,"given":"Olabisi C","family":"Akinlabi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwafemi A","family":"Popoola","sequence":"additional","affiliation":[{"name":"University College Hospital and College of Medicine , University of Ibadan, Ibadan ,","place":["Nigeria"]},{"name":"Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temitope O","family":"Alonge","sequence":"additional","affiliation":[{"name":"University College Hospital and College of Medicine , University of Ibadan, Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-7587","authenticated-orcid":false,"given":"Iruka N","family":"Okeke","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025072212053758300_ciaf056-B1","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.chest.2020.07.061","article-title":"SARS CoV-2 detection from upper and lower respiratory tract specimens: diagnostic and infection control implications","volume":"158","author":"Murphy","year":"2020","journal-title":"Chest"},{"key":"2025072212053758300_ciaf056-B2","doi-asserted-by":"crossref","first-page":"648660","DOI":"10.3389\/fmed.2021.648660","article-title":"SARS-CoV-2 viral shedding and transmission dynamics: implications of WHO COVID-19 discharge guidelines","volume":"8","author":"Badu","year":"2021","journal-title":"Front Med"},{"key":"2025072212053758300_ciaf056-B3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/M20-6448","article-title":"Convalescent plasma for the treatment of COVID-19: perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel","volume":"174","author":"Pau","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025072212053758300_ciaf056-B4","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1021\/acsomega.0c06335","article-title":"Fomite transmission, physicochemical origin of virus-surface interactions, and disinfection strategies for enveloped viruses with applications to SARS-CoV-2","volume":"6","author":"Casta\u00f1o","year":"2021","journal-title":"ACS Omega"},{"author":"World Health Organization","key":"2025072212053758300_ciaf056-B5"},{"key":"2025072212053758300_ciaf056-B6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijid.2020.06.067","article-title":"Coronavirus outbreak in Nigeria: burden and socio-medical response during the first 100 days","volume":"98","author":"Amzat","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025072212053758300_ciaf056-B7"},{"key":"2025072212053758300_ciaf056-B8","article-title":"Coronavirus vaccine tracker","volume":"5","author":"Corum","year":"2020","journal-title":"The New York Times"},{"key":"2025072212053758300_ciaf056-B9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines9020160","article-title":"COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates","volume":"9","author":"Sallam","year":"2021","journal-title":"Vaccines"},{"key":"2025072212053758300_ciaf056-B10","first-page":"248","article-title":"Assessment of adverse events following COVID-19 vaccination: a cross-sectional study in Ibadan, Nigeria","volume":"63","author":"Alao","year":"2022","journal-title":"Niger Med J"},{"key":"2025072212053758300_ciaf056-B11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4081\/jphia.2022.1720","article-title":"Restoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2 pandemic","volume":"13","author":"Ogunleye","year":"2022","journal-title":"J Public Health Afr"},{"author":"QIAGEN","key":"2025072212053758300_ciaf056-B12"},{"author":"NEBNext Ultra II FS DNA library prep kit for Illumina","key":"2025072212053758300_ciaf056-B13"},{"key":"2025072212053758300_ciaf056-B14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025072212053758300_ciaf056-B15","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"O\u2019Toole","year":"2021","journal-title":"Virus Evol"},{"key":"2025072212053758300_ciaf056-B16","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"key":"2025072212053758300_ciaf056-B17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2025072212053758300_ciaf056-B18","first-page":"e000093","article-title":"Microreact: visualizing and sharing data for genomic epidemiology and phylogeography","volume":"2","author":"Argim\u00f3n","year":"2016","journal-title":"Microb Genom"},{"author":"GISAID","key":"2025072212053758300_ciaf056-B19"},{"key":"2025072212053758300_ciaf056-B20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41467-022-28317-5","article-title":"Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria","volume":"13","author":"Ozer","year":"2022","journal-title":"Nat Commun"},{"key":"2025072212053758300_ciaf056-B21","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.12.21251658","article-title":"Emergence in late 2020 of multiple lineages of SARS-CoV-2 spike protein variants affecting amino acid position 677","author":"Hodcroft","year":"21, 2021","journal-title":"MedRxiv 21251658 [Preprint]"},{"key":"2025072212053758300_ciaf056-B22","doi-asserted-by":"crossref","first-page":"e0280756","DOI":"10.1371\/journal.pone.0280756","article-title":"SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: implications for epidemic control","volume":"18","author":"Adeyemi","year":"2023","journal-title":"PLoS One"},{"key":"2025072212053758300_ciaf056-B23","doi-asserted-by":"crossref","first-page":"eabq5358","DOI":"10.1126\/science.abq5358","article-title":"The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance","volume":"378","author":"Tegally","year":"2022","journal-title":"Science"},{"key":"2025072212053758300_ciaf056-B24","doi-asserted-by":"crossref","first-page":"taac037","DOI":"10.1093\/jtm\/taac037","article-title":"The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta","volume":"29","author":"Liu","year":"2022","journal-title":"J Travel Med"},{"key":"2025072212053758300_ciaf056-B25","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1038\/s41467-022-33328-3","article-title":"Household transmission of the SARS-CoV-2 Omicron variant in Denmark","volume":"13","author":"Lyngse","year":"2022","journal-title":"Nat Commun"},{"key":"2025072212053758300_ciaf056-B26","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"key":"2025072212053758300_ciaf056-B27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41467-023-36449-5","article-title":"Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria","volume":"14","author":"Olawoye","year":"2023","journal-title":"Nat Commun"},{"key":"2025072212053758300_ciaf056-B28","doi-asserted-by":"crossref","first-page":"e0173621","DOI":"10.1128\/JCM.01736-21","article-title":"Emergence of SARS-CoV-2 variant B.1.575.2, containing the E484 K mutation in the spike protein, in Pamplona, Spain, May to June 2021","volume":"59","author":"Trobajo-Sanmart\u00edn","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2025072212053758300_ciaf056-B29","first-page":"96","article-title":"Urbanization, spatial distribution of healthcare facilities and inverse care in Ibadan, Nigeria","volume":"10","author":"Adewoyin","year":"2018","journal-title":"Ghana J Geography"},{"key":"2025072212053758300_ciaf056-B30","first-page":"1032","article-title":"An epidemiological analysis of the recipients of the first dose of the first phase of COVID-19 vaccination in Oyo State, south-western Nigeria","volume":"39","author":"Olatunji","year":"2022","journal-title":"West Afr J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/Supplement_1\/S29\/63819472\/ciaf056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/Supplement_1\/S29\/63819472\/ciaf056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:05:48Z","timestamp":1753200348000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/Supplement_1\/S29\/8210487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":30,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf056","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,6,15]]}}}